Phase III, Randomized, Double‐blind, Placebo‐controlled Study to Evaluate the Efficacy and Safety of Teneligliptin Monotherapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise
Journal of Diabetes Investigation（2020）
Key words
China,Dipeptidyl peptidase-4 inhibitors,Type 2 diabetes mellitus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined